Lyuba Miteva

1.4k citations
56 papers · 1.0k indexed · h-index 20
Topics
Cytokine Signaling Pathways and Interactions (16 papers)Psoriasis: Treatment and Pathogenesis (13 papers)Immune Response and Inflammation (13 papers)

In The Last Decade

Lyuba Miteva

54 papers receiving 991 citations

Peers

Lyuba Miteva
Comparison fields: 5 of 99
  • Immunology 459
  • Oncology 272
  • Molecular Biology 223
  • Epidemiology 164
  • Pathology and Forensic Medicine 145
Replace Lakshmi Kannan with:
Lakshmi Kannan United States
Elaine Huang Australia
Nicholas T. Ventham United Kingdom
Koji Otani Japan
Hidetoshi Seki Japan
Fernando Botelho Canada
Francesca Zorzi Italy
Sriram Sampath India
Annemie J. Schuerwegh Belgium
Lyuba Miteva relative to Lakshmi Kannan United States Lakshmi Kannan's profile →
Citations per field
00.5×1.5×1.8×
Lakshmi Kannan · 1×
Citations per year

Countries citing papers authored by Lyuba Miteva

Since Specialization
Citations

This map shows the geographic impact of Lyuba Miteva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyuba Miteva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyuba Miteva more than expected).

Fields of papers citing papers by Lyuba Miteva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyuba Miteva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyuba Miteva. The network helps show where Lyuba Miteva may publish in the future.

Co-authorship network of co-authors of Lyuba Miteva

This figure shows the co-authorship network connecting the top 25 collaborators of Lyuba Miteva. A scholar is included among the top collaborators of Lyuba Miteva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyuba Miteva. Lyuba Miteva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 6
4 6
5 17
6 5
7 1
8 56
9 10
10 5
11 29
12 29
13 26
14 22
15 27
16 20
17 37
18 57
19 6
20 28

About Lyuba Miteva

Lyuba Miteva is a scholar working on Immunology, Biological Psychiatry and Rheumatology, having authored 56 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (16 papers), Psoriasis: Treatment and Pathogenesis (13 papers) and Immune Response and Inflammation (13 papers). The work is most often cited by research in Immunology (459 citations), Oncology (272 citations) and Pathology and Forensic Medicine (145 citations). Lyuba Miteva has collaborated with scholars based in Bulgaria, United Kingdom and India. Frequent co-authors include Spaska Stanilova, Noyko Stanilov, Zlatka Georgieva Dobreva, Irena Manolova, Mariana Ivanova, Румен Стоилов, Zoya Spassova, Tsvetelina Velikova, Maya Gulubova and Nonka Маteva. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026